Back
Speaker illustration

Doctor Angelo Laino

University of Naples Federico II, Naples (Italy)

Member of:

European Association of Percutaneous Cardiovascular Interventions

Presentations

Sex differences among elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention receiving ticagrelor 60 mg vs. 90 mg: a post-hoc analysis of a randomized trial

Event: EAPCI Summit 2026

Topic: Antiplatelet Drugs

Session: Pharmacology and pharmacotherapy

Access
Like
Thumbnail

Ticagrelor 60 mg vs. 90 mg in elderly ACS patients with vs. without diabetes undergoing percutaneous coronary intervention

Event: EAPCI Summit 2026

Topic: Cardiovascular Pharmacotherapy

Session: Tailoring antithrombotic therapy after PCI: balancing ischaemic and bleeding risks

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources